Circulating C-reactive protein and colorectal cancer risk: A report from the shanghai men's health study

Carcinogenesis

Volumn 34, Issue 12, 2013, Pages 2799-2803

  Wu, Jie ^a   Cai, Qiuyin ^a   Li, Honglan ^b   Cai, Hui ^a   Gao, Jing ^b   Yang, Gong ^a   Zheng, Wei ^a   Xiang, Yong Bing ^b   Shu, Xiao Ou ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER LOCALIZATION; CANCER RISK; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; HUMANS; MALE; MEN'S HEALTH; MIDDLE AGED; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 84889049500     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt288     Document Type: Article

References (42)

1. Siegel,R. et al. (2012) Cancer statistics, 2012. Cancer J. Clin., 62, 10-29.
2. Jemal,A. et al. (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev., 19, 1893-1907.
3. Center,M.M. et al. (2009) International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev., 18, 1688-1694.
4. Coussens,L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
5. Eaden,J.A. et al. (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut, 48, 526-535.
6. Laukoetter,M.G. et al. (2011) Intestinal cancer risk in Crohn's disease: a meta-analysis. J. Gastrointest. Surg., 15, 576-583.
7. Canavan,C. et al. (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment. Pharmacol. Ther., 23, 1097-1104.
8. Jess,T. et al. (2005) Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am. J. Gastroenterol., 100, 2724-2729.
9. Din,F.V. et al. (2010) Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut, 59, 1670-1679.
10. Cole,B.F. et al. (2009) Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J. Natl Cancer Inst., 101, 256-266.
11. Bastiaannet,E. et al. (2012) Use of aspirin postdiagnosis improves survival for colon cancer patients. Br. J. Cancer, 106, 1564-1570.
12. Arber,N. et al.; PreSAP Trial Investigators. (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N. Engl. J. Med., 355, 885-895.
13. Ruder,E.H. et al. (2011) Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am. J. Gastroenterol., 106, 1340-1350.
14. Watson,A.J. et al. (2011) Colon cancer: a civilization disorder. Dig. Dis., 29, 222-228.
15. Gabay,C. et al. (1999) Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med., 340, 448-454.
16. Erlinger,T.P. et al. (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA, 291, 585-590.
17. Gunter,M.J. et al. (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res., 66, 2483-2487.
18. Otani,T. et al.; Japan Public Health Center-Based Prospective Study Group. (2006) Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer Epidemiol. Biomarkers Prev., 15, 690-695.
19. Il'yasova,D. et al. (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol. Biomarkers Prev., 14, 2413-2418.
20. Zhang,S.M. et al. (2005) C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann. Intern. Med., 142, 425-432.
21. Ito,Y. et al.; JACC Study Group. (2005) Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC Study. J. Epidemiol., 15 (suppl. 2), S185-S189.
22. Trichopoulos,D. et al. (2006) Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol. Biomarkers Prev., 15, 381-384.
23. Siemes,C. et al. (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J. Clin. Oncol., 24, 5216-5222.
24. Tsilidis,K.K. et al. (2008) C-reactive protein and colorectal adenoma in the CLUE II cohort. Cancer Causes Control, 19, 559-567.
25. Allin,K.H. et al. (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J. Clin. Oncol., 27, 2217-2224.
26. Dymicka-Piekarska,V. et al. (2007) Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer. Thromb. Res., 120, 585-590.
27. Kwon,K.A. et al. (2010) Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer, 10, 203.
28. Groblewska,M. et al. (2008) Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. Clin. Chem. Lab. Med., 46, 1423-1428.
29. Ishizuka,M. et al. (2012) C-reactive protein is associated with distant metastasis of T3 colorectal cancer. Anticancer Res., 32, 1409-1415.
30. Koike,Y. et al. (2008) Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J. Surg. Oncol., 98, 540-544.
31. Chung,Y.C. et al. (2003) Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur. J. Gastroenterol. Hepatol., 15, 369-373.
32. Nozoe,T. et al. (1998) Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am. J. Surg., 176, 335-338.
33. Aleksandrova,K. et al. (2010) Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am. J. Epidemiol., 172, 407-418.
34. Yang,G. et al. (2011) Green tea consumption and colorectal cancer risk: a report from the Shanghai Men's Health Study. Carcinogenesis, 32, 1684-1688.
35. Cai,H. et al. (2007) Dietary patterns and their correlates among middleaged and elderly Chinese men: a report from the Shanghai Men's Health Study. Br. J. Nutr., 98, 1006-1013.
36. Tsilidis,K.K. et al. (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int. J. Cancer, 123, 1133-1140.
37. Karin,M. et al. (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol., 5, 749-759.
38. Grivennikov,S.I. et al. (2010) Immunity, inflammation, and cancer. Cell, 140, 883-899.
39. Grivennikov,S. et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell, 15, 103-113.
40. Popivanova,B.K. et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest., 118, 560-570.
41. Joyce,J.A. et al. (2009) Microenvironmental regulation of metastasis. Nat. Rev. Cancer, 9, 239-252.
42. Orosz,P. et al. (1993) Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med., 177, 1391-1398.